Dispensary Retail Strategy

Summary

This reference covers three interconnected pillars of dispensary retail strategy: menu optimization (category mix ratios and assortment depth tailored to store type and market maturity), competitive positioning (four distinct strategic frameworks with tradeoffs, named examples, and a decision tree), and vendor selection and negotiation (evaluation criteria, margin benchmarks by category, payment term norms, and co-marketing expectations). Together, these form the consultant playbook that Claude draws on when advising dispensary operators on how to set up, differentiate, and sustain a cannabis retail operation.

The organizing framework is a dual-axis segmentation matrix crossing four store formats (single-store independent, small chain, MSO/large chain, delivery-only/hub) against four market positioning types (premium/boutique, value/volume, medical-focused, lifestyle/brand-forward). Category mix ratios, assortment depth, and competitive strategy recommendations flow from where a store sits in this matrix. All benchmarks are presented as ranges with market-maturity context and date-tagged to the source period. State-specific retail strategy notes for all legal US states are organized by market-maturity tier.

For product taxonomy details (categories, weights, attributes), see product-taxonomy.md. For state legal status, licensing structures, and compliance requirements, see legality.md. For cultivation quality indicators and grow method positioning, see cultivation.md.

Store Type Segmentation Matrix

The retail cannabis market segments along two independent axes: store format (operational scale and delivery model) and market positioning (brand identity and customer value proposition). Most strategic recommendations in this file are indexed to a specific cell or row in this matrix.

Store Formats (D-08)

| Format | Store Count | Typical Characteristics | |--------|-------------|------------------------| | Single-store independent | 1 | Owner-operated, deep community ties, lean staffing, nimble on inventory decisions. Represents ~60-70% of US dispensaries (as of 2025). | | Small chain | 2-5 | Regional brand identity, shared purchasing power, some operational standardization. Often family-owned or small partnership groups. | | MSO / large chain | 6+ | Multi-state or large in-state operators. Centralized purchasing, brand standards, data-driven category management. Examples: Curaleaf, Trulieve, Green Thumb Industries. | | Delivery-only / hub | 0 storefronts | No customer-facing retail space. Orders via app/web, fulfilled from warehouse or dark store. Growing in CA, legal in select states. |

Market Positioning Types (D-09)

| Positioning | Core Value Proposition | Price Tier | Target Customer | |-------------|----------------------|------------|-----------------| | Premium/Boutique | Curated quality, craft products, elevated experience | High | Quality-focused consumers, connoisseurs, tourists | | Value/Volume | Everyday low prices, broad selection, convenience | Low-Mid | Price-sensitive regulars, deal-hunters, habitual users | | Medical-Focused | Patient care, consultative service, compliance excellence | Mid-High | Medical patients, wellness-oriented consumers | | Lifestyle/Brand-Forward | Experiential retail, brand partnerships, culture | High | Brand-loyal consumers, social consumers, tourists |

Viable Combinations (D-10)

Not all 16 matrix cells are realistic. The following 8 combinations represent the vast majority of operating dispensaries. Unlikely combinations are noted with brief rationale.

| Format | Premium/Boutique | Value/Volume | Medical-Focused | Lifestyle/Brand-Forward | |--------|-----------------|--------------|-----------------|------------------------| | Single-store independent | VIABLE -- craft/curated niche | VIABLE -- neighborhood discount | VIABLE -- patient care focus | UNLIKELY -- hard to sustain brand identity alone without chain scale | | Small chain (2-5) | VIABLE -- regional luxury | VIABLE -- everyday low price | VIABLE -- multi-location patient network | VIABLE -- lifestyle brand rollout (early stage) | | MSO / large chain (6+) | UNLIKELY -- scale conflicts with exclusivity perception | VIABLE -- dominant play for MSOs | VIABLE -- medical multi-state (Trulieve FL model) | VIABLE -- e.g., Cookies retail, Planet 13 | | Delivery-only / hub | UNLIKELY -- no physical experience to anchor premium | VIABLE -- convenience + value | VIABLE -- patient convenience (chronic conditions) | UNLIKELY -- brand experience requires a storefront |

Viable combos covered in detail below: 8 cells marked VIABLE. The 4 UNLIKELY cells fail because either the positioning requires a physical experience that the format cannot deliver (premium delivery, lifestyle delivery) or the format's scale undermines the positioning's value proposition (MSO premium, where scale dilutes exclusivity).

Category Mix Ratios by Store Type (RETAIL-01)

Category mix is the single most impactful merchandising decision a dispensary makes. The tables below provide target SKU distribution and revenue share by positioning type, with adjustments for market maturity. All benchmarks reflect aggregate industry data and practitioner experience across 300+ Treez organizations.

National category share benchmarks (as of 2025, Headset/BDSA aggregate):

| Category | National SKU Share | National Revenue Share | Trend Direction | |----------|--------------------|----------------------|-----------------| | Flower | 30-40% | 33-38% | Declining share (was ~45% in 2022) | | Pre-Rolls | 10-15% | 10-14% | Growing, driven by infused pre-rolls | | Vapes | 18-25% | 25-32% | Growing -- overtook flower revenue in CA late 2025 | | Concentrates | 8-12% | 8-12% | Stable to slightly growing | | Edibles | 12-18% | 10-15% | Stable, beverages growing within subcategory | | Tinctures/Topicals | 3-7% | 2-5% | Stable, medical-leaning | | Accessories | 2-5% | 1-3% | Minimal margin contribution |

Source: Industry aggregates, practitioner experience. All figures as of 2025.

Premium/Boutique Positioning

Target SKU distribution (as of 2025):

| Category | SKU % | Revenue % | Key Notes | |----------|-------|-----------|-----------| | Flower | 30-35% | 35-40% | Emphasize indoor/craft/living soil. Fewer but higher-quality options. Brands: Alien Labs, Jungle Boys, Connected Cannabis | | Pre-Rolls | 10-15% | 8-12% | Infused pre-rolls as differentiator. Branded collabs (e.g., Cookies, Alien Labs). Minimal commodity singles | | Vapes | 15-20% | 20-25% | Live resin/rosin carts dominant. Skip distillate unless intentional budget tier. Brands: Raw Garden, Friendly Farms, Stiiizy (live resin line) | | Concentrates | 10-15% | 10-15% | Solventless focus: hash rosin, live rosin, cold cure. Curated drops from craft extractors. Tier 6 full-melt as anchor | | Edibles | 15-20% | 10-15% | Gourmet/craft brands. Low-dose wellness line. Cannabis beverages as emerging differentiator. Nano-emulsion options | | Tinctures/Topicals | 5-10% | 3-5% | Wellness positioning. CBD-forward and ratio products. Premium topical brands | | Accessories | 2-5% | 1-2% | Curated devices only -- high-end batteries, designer glass. No commodity items |

Assortment depth: Narrow and deep. 200-400 total SKUs. Fewer brands (15-30), deeper relationships. Every SKU on the shelf should tell a story.

Signature play: Exclusive drops, limited-run strains, vendor partnerships. A premium store's competitive moat is access to products competitors cannot stock.

Market maturity adjustment: In mature markets (CA, CO, WA, OR), premium positioning requires genuinely differentiated product -- generic "top shelf" flower is not enough. In emerging markets (NY, NJ, OH, MN), premium works earlier because supply is limited and consumers have fewer choices. Premium stores in emerging markets can command 20-30% higher margins than the same positioning in mature markets (as of 2025).

Value/Volume Positioning

Target SKU distribution (as of 2025):

| Category | SKU % | Revenue % | Key Notes | |----------|-------|-----------|-----------| | Flower | 30-40% | 30-35% | Full spectrum from budget ($3-5/g outdoor) to mid-shelf ($8-12/g indoor). House brand flower if margins support it | | Pre-Rolls | 12-18% | 12-16% | Multi-packs and bulk packs drive volume. $1-3 singles as loss leaders. Machine-rolled for consistency and cost | | Vapes | 18-25% | 25-30% | Mix of distillate (value tier) and live resin (mid tier). Disposables growing share for convenience factor | | Concentrates | 5-10% | 5-10% | Focus on solvent-based at accessible price points. Wax, shatter, sugar. Limited solventless unless market demands it | | Edibles | 15-20% | 12-18% | Broad selection across gummies, chocolates, beverages. Value packs (200-500mg). Daily-use pricing | | Tinctures/Topicals | 3-5% | 2-4% | Basic selection for medical crossover customers. RSO as value medical option | | Accessories | 3-5% | 1-3% | Budget batteries, papers, cones. Functional, not aspirational |

Assortment depth: Wide and shallow. 400-800 total SKUs. More brands (30-60), shallower per-brand depth. Breadth of selection is the competitive advantage.

Signature play: Everyday low prices, daily deals rotation, loyalty programs with real value (not token points). Price matching. Bulk discounts. First-time customer specials.

Market maturity adjustment: Value/volume positioning is most viable in open-license markets with price compression (CA, CO, OR, OK, MI). In limited-license markets (IL, NJ, CT), value positioning is harder to sustain because wholesale costs are higher and competition is artificially constrained. Value stores in oversaturated markets face a race to the bottom -- must control COGS aggressively (as of 2025).

Medical-Focused Positioning

Target SKU distribution (as of 2025):

| Category | SKU % | Revenue % | Key Notes | |----------|-------|-----------|-----------| | Flower | 25-30% | 28-33% | Balanced indica/sativa/hybrid. Strain-specific with documented terpene profiles. CBD-dominant options mandatory | | Pre-Rolls | 8-12% | 6-10% | Standard pre-rolls for convenience. Infused for high-potency medical needs. CBD pre-rolls | | Vapes | 15-20% | 18-22% | Broad spectrum of formulations. Ratio carts (1:1, 2:1, CBD-dominant). Temperature-controlled devices for precision | | Concentrates | 5-8% | 5-8% | RSO is the anchor product. Full-spectrum extracts. Medical patients value consistency over novelty | | Edibles | 12-18% | 12-15% | Precise dosing paramount. Low-dose (2.5-5mg) options. Capsules and tinctures often preferred over gummies for medical use | | Tinctures/Topicals | 12-18% | 10-15% | Highest allocation of any positioning type. Full ratio range. Topicals for localized pain. Transdermal patches for sustained delivery | | Accessories | 2-4% | 1-2% | Medical-grade vaporizers. Dosing syringes. Pill organizers |

Assortment depth: Moderate and purpose-driven. 250-500 total SKUs. Brands selected for consistency and lab-testing transparency. Product selection driven by patient outcome categories (pain, sleep, anxiety, appetite, inflammation) rather than brand hype.

Signature play: Consultative service. Pharmacist or nurse on staff (where regulations allow). Dosing guidance. Patient intake forms. Outcome tracking. The competitive moat is trust and expertise, not product novelty.

Market maturity adjustment: Medical-focused positioning is strongest in medical-only states (FL, PA, OK, OH pre-rec) and dual-program states where medical cardholders get tax benefits and higher purchase limits (IL, NJ, MD). In mature rec markets (CA, CO), pure medical positioning has a shrinking addressable market as recreational consumers dominate. Medical stores in rec states must decide whether to serve the medical niche or pivot (as of 2025).

Lifestyle/Brand-Forward Positioning

Target SKU distribution (as of 2025):

| Category | SKU % | Revenue % | Key Notes | |----------|-------|-----------|-----------| | Flower | 25-35% | 30-35% | Brand-curated selection. Limited drops and exclusives. Packaging and bag appeal are paramount. Brands: Cookies, Lemonnade, Backpackboyz | | Pre-Rolls | 12-18% | 10-15% | Branded collaborations. Design-forward packaging. Infused pre-rolls with cultural cachet | | Vapes | 18-25% | 22-28% | Branded hardware ecosystems (Stiiizy, Pax). Design-led disposables. Live resin fills with brand storytelling | | Concentrates | 8-12% | 8-12% | Curated drops from hype extractors. Limited-edition collabs. Social media-friendly packaging | | Edibles | 12-18% | 10-14% | Lifestyle brands (Kiva, Wyld, CANN beverages). Instagrammable packaging. Low-dose social formats | | Tinctures/Topicals | 2-5% | 2-3% | Minimal -- lifestyle consumers rarely seek tinctures. Wellness topicals only if brand-aligned | | Accessories | 5-8% | 3-5% | Branded merchandise. Designer accessories. Co-branded hardware. Apparel if the brand supports it |

Assortment depth: Curated and brand-led. 250-500 total SKUs. Fewer brands (10-25), but each brand gets significant shelf space, visual merchandising, and storytelling. Brands are chosen for cultural relevance, not just product quality.

Signature play: Experiential retail -- the store IS the brand experience. Pop-up events, brand ambassador days, limited drops with lines out the door. Social media integration. In-store design that's worth photographing. The competitive moat is cultural relevance and brand access.

Market maturity adjustment: Lifestyle positioning thrives in tourism-heavy markets (Las Vegas, Los Angeles, Denver, Portland) and in markets with strong cannabis culture (Northern CA, NYC). In smaller or more conservative markets, lifestyle positioning can feel incongruent with local consumer expectations. Requires significant foot traffic to sustain -- suburban locations struggle with this model (as of 2025).

Delivery-Only / Hub Model

Target SKU distribution (as of 2025):

| Category | SKU % | Revenue % | Key Notes | |----------|-------|-----------|-----------| | Flower | 20-30% | 25-30% | Fewer SKUs than brick-and-mortar due to freshness concerns. Pre-packaged only. Smaller format sizes (1g, 3.5g) preferred for delivery | | Pre-Rolls | 12-18% | 12-16% | Strong delivery format -- pre-packaged, consistent, impulse-friendly. Multi-packs popular for delivery orders | | Vapes | 25-35% | 30-38% | Highest vape allocation of any format. Vapes are ideal for delivery: compact, no breakage, no freshness degradation. Disposables especially strong | | Concentrates | 5-8% | 5-8% | Limited selection. Delivery consumers skew convenience-oriented rather than connoisseur | | Edibles | 18-25% | 15-20% | Second highest edible allocation. Shelf-stable, easy to package, popular for planned consumption | | Tinctures/Topicals | 3-5% | 2-4% | Medical crossover segment. Tinctures travel well | | Accessories | 1-3% | 0-1% | Minimal -- batteries and papers only if margin-positive |

Assortment depth: Narrow and optimized. 150-300 total SKUs. Every SKU must justify its warehouse space. SKU velocity is the primary curation metric -- slow movers get cut faster than in brick-and-mortar.

Signature play: Convenience and speed. Order-to-door in 60-90 minutes. Simple, clean menu organized by effect or occasion rather than product type. Subscription models for regular customers. Reorder-from-history UI.

Format constraints: No budtender interaction reduces impulse upselling. Menu design and product photography carry more weight. Return/exchange logistics are costlier. Freshness management for flower requires tighter inventory turns -- target 2-3 week shelf life for flower in delivery (as of 2025).

Assortment Depth Guidelines

Total SKU counts and brand/product depth by store format, independent of positioning:

| Metric | Single-Store Independent | Small Chain (2-5) | MSO / Large Chain (6+) | Delivery-Only / Hub | |--------|--------------------------|--------------------|------------------------|---------------------| | Total SKUs | 200-400 | 300-600 | 400-1,000 | 150-300 | | Total Brands | 15-35 | 25-50 | 40-100 | 10-25 | | Flower Strains | 15-30 | 25-50 | 40-80 | 10-20 | | Unique Edible SKUs | 30-60 | 50-100 | 80-150 | 25-50 | | Vape SKUs | 30-60 | 50-100 | 80-150 | 40-80 | | New SKU Intro Rate | 5-10/week | 8-15/week | 15-30/week | 3-8/week | | SKU Turnover Rate | 10-15% quarterly | 12-18% quarterly | 15-25% quarterly | 15-20% quarterly |

All figures as of 2025. SKU counts assume a typical single-location footprint; multi-location chains may stock different assortments per store based on local demand.

The 30/70 rule (as of 2025): Across cannabis retail, roughly 30% of SKUs drive 70% of revenue. This ratio is consistent across positioning types and store formats. Use it as a diagnostic -- if more than 40% of your SKUs are contributing less than 5% each to revenue, your assortment is too wide.

Category Mix Adjustments by Market Maturity

Market maturity dramatically affects optimal category mix. A dispensary in a year-one market will have a fundamentally different mix than the same positioning type in a decade-old market. The adjustments below layer on top of the positioning-specific tables above.

Mature markets (5+ years legal rec: CA, CO, WA, OR, NV):

| Category | Adjustment vs National Average | Rationale | |----------|-------------------------------|-----------| | Flower | -3 to -5 percentage points SKU share | Consumer diversification away from flower. More categories compete for wallet share (as of 2025) | | Vapes | +3 to +5 percentage points | Convenience-driven category grows with market maturity. Disposables accelerating in mature markets | | Edibles | +2 to +3 percentage points | Beverage subcategory expansion. Low-dose social formats (2.5-5mg) growing fastest | | Concentrates | +1 to +2 percentage points | Consumer sophistication drives interest in solventless and premium extracts | | Pre-Rolls | Flat to +1 percentage point | Infused pre-rolls growing but standard pre-rolls commoditizing |

Emerging markets (0-4 years legal rec: NY, NJ, OH, MN, MD, MO, CT):

| Category | Adjustment vs National Average | Rationale | |----------|-------------------------------|-----------| | Flower | +3 to +8 percentage points SKU share | Flower dominates early-market consumer behavior. New consumers start with flower (as of 2025) | | Vapes | -2 to -3 percentage points | Smaller installed base of vape hardware. Growing as consumers discover category | | Edibles | Flat to +2 percentage points | Edibles appeal to new consumers who don't want to smoke. Gummies as entry point | | Concentrates | -3 to -5 percentage points | Consumer knowledge gap -- concentrates require education and hardware. Slower adoption | | Pre-Rolls | +1 to +3 percentage points | Convenience for new consumers. Pre-rolls lower the barrier to trial |

Medical-only markets (FL, PA, OK, and others):

| Category | Adjustment vs National Average | Rationale | |----------|-------------------------------|-----------| | Flower | -5 to -8 percentage points | Medical patients diversify into dosing-precise formats faster. RSO, tinctures, capsules gain share | | Tinctures/Topicals | +5 to +10 percentage points | Medical patients disproportionately use precise-dosing, non-smokable formats (as of 2025) | | Vapes | Flat | Medical patients value vapes for dosing precision and discretion | | Edibles | +2 to +4 percentage points | Capsules and precisely-dosed edibles preferred by medical patients |

Common Category Mix Mistakes

Mistake 1: Over-indexing on flower in a mature market. Dispensaries that allocate 45%+ of SKUs to flower in CA or CO are carrying slow-moving inventory. Flower velocity has declined 15-20% in mature markets over the past 3 years (as of 2025). The fix: shift 5-10% of flower SKUs to vapes, edibles, and pre-rolls.

Mistake 2: Under-stocking infused pre-rolls. Infused pre-rolls are the fastest-growing subcategory in most markets (30%+ YoY growth in several states as of 2025). Many dispensaries carry 2-3 infused pre-roll SKUs when the sweet spot is 8-15 for most formats. Infused carries 55-65% margin vs 50-55% for standard pre-rolls.

Mistake 3: Ignoring beverages. Cannabis beverages represent under 3% of national revenue but are growing 40-60% YoY in mature markets (as of 2025). Dispensaries that dismiss beverages miss the highest-margin edible subcategory and the "alcohol alternative" consumer segment. Stock 4-8 beverage SKUs minimum.

Mistake 4: Too many concentrate SKUs for the positioning. Value and medical stores that carry 30+ concentrate SKUs are over-investing in a category where their customers buy on price, not variety. Match concentrate depth to your positioning: premium stores need variety (15-25 SKUs), value stores need value (5-10 SKUs at competitive prices).

Mistake 5: Commodity accessories. Batteries and papers carry 30-40% margin -- fine, but not worth significant shelf or menu space. Premium and lifestyle stores should curate 5-10 accessory SKUs with design appeal. Value stores should carry commodity basics only. No positioning benefits from 50+ accessory SKUs.

Competitive Positioning Frameworks (RETAIL-02)

Premium/Boutique Strategy

Core thesis: Curate the best, charge accordingly, and deliver an experience that justifies the price. A premium dispensary is not just a store with expensive products -- it is a trust-based relationship with customers who value quality over price.

Target customer: Quality-focused consumers with disposable income. Cannabis connoisseurs who understand strain genetics, extraction methods, and terpene profiles. Tourists in destination markets. Wellness-oriented professionals seeking elevated experiences rather than just getting high.

Competitive moat: Access to products competitors cannot stock. Exclusive vendor relationships. Knowledgeable staff who can discuss terpene profiles, grow methods, and extraction techniques with credibility. A physical environment that signals quality (lighting, fixtures, layout, scent).

Named examples:

MedMen (early era, 2018-2020): Pioneered the "Apple Store of weed" aesthetic. Premium positioning with clean design, uniform pricing, and tech-forward checkout. Ultimately failed due to operational excess and governance issues -- but the positioning concept was validated. Lesson: premium positioning requires operational discipline, not just beautiful stores.
Cookies (retail locations): Brand-forward premium with cultural cachet. The Cookies retail experience is as much about the brand as the product. Limited drops, exclusive genetics (Berner's Cookies strains), and hip-hop culture integration. Works in markets with strong brand awareness.
The Cannabist (Columbia Care): Medical-roots premium positioning. Consultative staff, clean clinical aesthetic, emphasis on product knowledge and patient outcomes. Differentiated from lifestyle-premium by leaning into education over culture.

Tradeoffs:

Higher margin per unit (60-70% gross margin on curated items) but lower transaction volume
Requires curated vendor relationships that take time to build -- cannot be replicated overnight
Staff training costs are higher -- budtenders must be genuine product experts, not just cashiers
Inventory risk is concentrated: a limited-edition drop that doesn't sell sits on the shelf
Customer base is smaller but more loyal and higher LTV
Vulnerable to economic downturns -- luxury cannabis is the first budget cut

When it works:

Limited-license markets where supply is constrained and consumers have fewer choices (IL, NJ, CT pre-maturity)
Affluent neighborhoods and shopping districts with high foot traffic (Beverly Hills, Scottsdale, Ann Arbor)
Tourist corridors where visitors are willing to pay premium for the experience (Las Vegas Strip, downtown Denver, Santa Monica)
Markets with strong cannabis culture where connoisseurship is valued (Northern CA, Portland, Boulder)

When it fails:

Oversaturated markets where price competition erodes premium perception (parts of CA, CO, OK, OR as of 2025)
Locations with limited foot traffic -- premium stores need walk-in volume because their repeat customer base is smaller
Markets without established cannabis culture where consumers don't yet distinguish between quality tiers
When operators confuse premium aesthetics with premium operations -- a beautiful store with poorly trained staff and stale inventory loses credibility fast

Value/Volume Strategy

Core thesis: Everyday low prices, broad selection, and convenience. Win on price, volume, and operational efficiency. The cannabis equivalent of Walmart or Costco -- not glamorous, but reliably profitable when executed well.

Target customer: Price-sensitive regular consumers. Daily or weekly cannabis users who optimize for cost-per-dose. Deal-hunters who comparison-shop across dispensaries. Budget-conscious medical patients on fixed incomes.

Competitive moat: Purchasing power (especially for chains). Low operating costs. Efficient inventory management. Loyalty programs that lock in repeat visits. Location convenience (near residential areas, easy parking, quick in-and-out).

Named examples:

Curaleaf (value positioning): The largest US MSO by store count uses value positioning in many markets -- broad selection, competitive pricing, aggressive promotional calendars. Their scale enables wholesale purchasing power that independents cannot match. Curaleaf's "Select" house brand captures margin on value-tier products.
Local discount dispensaries (various): Every market has its "discount dispensary" that leads with daily deals, ounce specials, and BOGO promotions. In mature markets like Colorado and Oregon, some stores have pushed flower below $5/gram outdoor and $100/oz indoor to compete (as of 2025).

Tradeoffs:

Thin margins (40-50% gross) require high transaction volume to sustain
Vulnerable to price wars -- a new competitor opening nearby can force unsustainable discounting
Staff costs can be lower (less training required) but turnover may be higher
Inventory carrying costs are higher due to broader SKU assortment
Customer loyalty is lower -- value shoppers will switch to a cheaper competitor
Brand perception may limit future pivot to premium -- "discount" identity is sticky

When it works:

Open-license markets with significant price compression (OK, MI, CA, CO, OR as of 2025)
Competitive markets where multiple dispensaries serve the same geographic area
Suburban and rural locations where convenience and price outweigh experience
Markets with high daily-use consumer density (college towns, working-class neighborhoods)

When it fails:

Limited-license markets where wholesale costs are high and competition is artificially constrained (IL, NJ, CT)
Markets where minimum pricing regulations prevent deep discounting (some Canadian provinces; no US states currently, but watch for regulatory shifts)
Locations with high rent and operating costs that don't support thin margins (downtown urban cores)
When operators chase volume without controlling COGS -- revenue without margin is not a business

Medical-Focused Strategy

Core thesis: Patient-first, consultative, compliance-excellent. Win on trust, expertise, and outcomes. The medical dispensary is closer to a pharmacy than a retail store -- staff are advisors, not salespeople.

Target customer: Medical cannabis patients across all conditions (chronic pain, anxiety, insomnia, PTSD, epilepsy, cancer-related symptoms, autoimmune conditions). Wellness-oriented consumers who prefer a clinical setting. Older consumers uncomfortable with recreational dispensary environments. Caregivers purchasing for patients.

Competitive moat: Staff expertise (pharmacists, nurses, or well-trained patient consultants). Patient intake processes and outcome tracking. Compliance track record. Relationships with recommending physicians. Trust built through consistent, evidence-informed guidance.

Named examples:

Trulieve (Florida medical roots): Built the largest dispensary network in the US starting from Florida's medical-only market. Deep patient relationships, vertical integration, and medical-first branding. Their patient count in FL exceeded 1 million registrations. As FL voted against recreational in 2024, Trulieve's medical positioning proved durable.
Columbia Care / The Cannabist: Multi-state medical operator with clinical positioning. Pharmacist consultations in select locations. Patient education programs. Evolved from pure medical to hybrid med/rec as states legalized.

Tradeoffs:

Smaller addressable market than recreational -- medical cardholders are a subset of total cannabis consumers
Higher service costs per customer (longer consultations, intake processes, follow-up)
Customer loyalty is significantly stickier -- patients who find effective products are reluctant to switch dispensaries
Regulatory compliance costs are higher in medical programs (patient record-keeping, product tracking, physician relationships)
Revenue per customer can be higher due to tax advantages for medical purchases and higher purchase limits
Staff recruitment is harder -- finding genuinely knowledgeable patient consultants requires investment in training or hiring from healthcare

When it works:

Medical-only states where recreational sales are not yet legal (FL, PA, OH pre-2024 rec launch, and medical-only states like AL, KY, MS)
States with separate medical and recreational programs where medical cardholders get real benefits (tax savings in IL, NJ, MD; higher limits in MA, MI)
Communities with older demographics or conservative attitudes toward recreational cannabis
Near healthcare facilities, rehabilitation centers, or retirement communities

When it fails:

Mature recreational markets where the medical program has shrunk to a small fraction of total sales (CO, WA, OR -- medical share under 15% of total market as of 2025)
Markets where the medical card offers no meaningful benefit over recreational purchase (no tax break, same limits, same products)
When operators maintain the medical label but don't invest in the consultative service that justifies it -- a "medical" dispensary with no patient consultation is just a dispensary with a smaller customer base

Lifestyle/Brand-Forward Strategy

Core thesis: The store is the experience. Products are curated not just for quality but for cultural relevance, brand storytelling, and aesthetic cohesion. Win on brand access, exclusivity, and the in-store experience.

Target customer: Brand-loyal cannabis consumers who follow specific brands on social media. Social consumers who value the cultural and communal aspects of cannabis. Tourists and visitors seeking a destination experience. Younger demographics (21-35) who treat cannabis consumption as a lifestyle element.

Competitive moat: Exclusive brand partnerships and access to limited-edition products. Physical store design that creates social media-worthy experiences. Brand ambassador programs and in-store events. Cultural relevance and community engagement. First-mover advantage on emerging brands.

Named examples:

Cookies (Berner): The blueprint for lifestyle cannabis retail. Cookies retail locations are brand temples -- specific color palette (blue), specific music, specific energy. The product (Cookies genetics, Lemonnade, Grandiflora collabs) is inseparable from the brand experience. Requires genuine brand equity to pull off.
Planet 13 (Las Vegas): The "cannabis entertainment complex" -- 112,000 sq ft flagship on the Las Vegas Strip. Interactive displays, LED installations, aerial performers. Positioned as a tourist attraction first, dispensary second. Generates $100M+ annual revenue from a single location (as of 2024).
Stiiizy (retail locations): Hardware ecosystem brand with dedicated retail. The Stiiizy retail experience centers on the proprietary pod system ecosystem -- devices, merchandise, and brand culture. Vertical integration from extraction to retail.

Tradeoffs:

Brand dependency -- if your anchor brand loses relevance, your positioning collapses
High buildout costs for experiential retail design ($500K-$2M+ for flagship locations as of 2025)
Requires significant foot traffic to sustain -- location selection is critical
Product exclusivity is a double-edged sword: exclusive drops drive traffic but limit vendor diversification
Cultural relevance requires constant investment in events, social media, and community presence
Not replicable at scale without diluting the exclusivity that makes it work (the Cookies scaling challenge)

When it works:

Tourism markets where dispensaries are destinations, not errands (Las Vegas, Los Angeles, Denver, Portland, Miami)
Brand-dense markets where consumers have strong brand loyalties and follow cannabis culture (CA, CO)
High foot traffic urban locations with young, experience-seeking demographics
Markets where cannabis culture is mainstream and celebrated rather than stigmatized

When it fails:

Suburban and rural markets where consumers prioritize convenience and price over experience
Markets without established cannabis culture or brand awareness
Locations with limited foot traffic -- lifestyle stores cannot survive on repeat locals alone
When operators attempt the lifestyle play without genuine brand partnerships -- a generic dispensary with trendy decor is not lifestyle positioning

Positioning Decision Tree

Use this decision tree to recommend a positioning strategy based on a dispensary's market context and operational characteristics:

Step 1: Market Type

Mature recreational market (5+ years of legal sales) --> Go to Step 2
Emerging recreational market (0-4 years of legal sales) --> Premium or Medical have first-mover advantage. Go to Step 3
Medical-only market --> Medical-focused is the default. Consider Value if market has many licensees

Step 2: License Environment

Open or liberal licensing (many competitors) --> Value/Volume unless strong differentiator exists. Go to Step 3
Limited licensing (few competitors) --> Premium or Lifestyle viable. Go to Step 3

Step 3: Location Profile

Tourist corridor / high foot traffic --> Lifestyle or Premium
Affluent residential / shopping district --> Premium
Suburban / residential neighborhood --> Value/Volume or Medical
Near healthcare / older demographics --> Medical-focused
Urban core / young demographics --> Lifestyle or Value depending on brand access

Step 4: Operator Capabilities

Strong brand relationships and exclusive access --> Lifestyle or Premium
Purchasing power and operational efficiency --> Value/Volume
Healthcare background or clinical staff --> Medical-focused
Deep pockets for buildout and marketing --> Lifestyle
Lean operations and low overhead --> Value/Volume

Step 5: Customer Base Reality

Validate the above recommendation against actual customer demographics. If 60%+ of your expected customer base is price-sensitive daily users, Value/Volume will outperform Premium regardless of location.

Vendor Selection & Negotiation (D-20, D-21)

Vendor relationships are the operational backbone of dispensary retail. The right vendor mix determines product quality, margin structure, and competitive differentiation. Cannabis wholesale dynamics differ significantly from traditional retail due to cash-dominant transactions, limited banking access, compliance overhead, and the perishable nature of flower products.

Vendor Evaluation Framework

Score each vendor candidate across six criteria on a 1-5 scale. Weight the criteria based on your positioning type.

| Criterion | Description | Premium Weight | Value Weight | Medical Weight | Lifestyle Weight | |-----------|-------------|----------------|--------------|----------------|------------------| | Product Quality | Consistency of cannabinoid/terpene profiles, visual appeal, lab test reliability | 5 | 3 | 5 | 4 | | Margin Structure | Wholesale pricing, volume discounts, promotional allowances | 3 | 5 | 3 | 3 | | Payment Terms | COD, net terms, credit availability, flexibility | 3 | 5 | 3 | 3 | | Marketing Support | Pop-up days, demo events, co-branded content, social media | 3 | 2 | 2 | 5 | | Supply Reliability | Consistent availability, fill rates, delivery reliability, minimum order flexibility | 4 | 5 | 5 | 3 | | Compliance Record | Clean lab results, proper licensing, regulatory history, recall responsiveness | 5 | 3 | 5 | 4 |

Evaluation process:

Score each vendor on 1-5 per criterion
Multiply by the weight for your positioning type
Sum the weighted score (max 150 for any positioning type)
Vendors scoring below 60% of max (90 points) warrant caution
Vendors scoring below 40% of max (60 points) should generally be avoided

Red flags in vendor evaluation:

Inconsistent lab results across batches (quality control issues)
History of compliance violations or product recalls
Unwillingness to offer samples before initial order
Pressure to take large minimums on first order
No marketing support or willingness to do in-store events
Payment terms that are significantly worse than market norms

Margin Expectations by Category (D-21)

Retail margins in cannabis vary by category, market maturity, and product tier. The ranges below reflect typical margins across US dispensaries. Actual margins depend on wholesale negotiations, volume, and local market conditions.

| Category | Typical Retail Margin | Wholesale Cost Range | Notes | Trend | |----------|----------------------|---------------------|-------|-------| | Flower | 45-55% retail margin | $800-2,000/lb depending on quality tier (as of 2025) | Indoor premium commands higher margin. Outdoor/greenhouse margins compressed in mature markets. Top-shelf indoor: $1,400-2,000/lb wholesale, selling at $35-60/eighth retail | Margins compressing in mature markets, holding in limited-license states | | Pre-Rolls | 50-60% retail margin | $2-6/unit wholesale for singles (as of 2025) | Infused pre-rolls carry 55-65% margin -- the highest in the pre-roll segment. Standard pre-rolls at commodity pricing in mature markets | Infused driving category margin uplift | | Vapes | 40-50% retail margin | $12-25/unit wholesale for 1g carts (as of 2025) | Live resin/rosin carts: higher wholesale cost but higher retail margin. Distillate carts: lower margin but higher velocity. Branded hardware (Stiiizy pods) locks consumers into ecosystem | Brand premium enabling margin hold despite market maturation | | Concentrates | 45-55% retail margin | $8-25/g wholesale depending on type (as of 2025) | Solventless commands premium: hash rosin $18-30/g wholesale vs shatter $6-10/g. Curated drops from craft extractors can exceed 60% margin on limited releases | Solventless share growing, lifting average category margin | | Edibles | 50-60% retail margin | $3-10/unit wholesale per 100mg package (as of 2025) | Beverages at higher margin than gummies due to novelty and lower market saturation. Bulk packs (200-500mg) have lower per-mg margin but higher AOV. Nano-emulsion products command premium | Beverages emerging as highest-margin edible subcategory | | Tinctures/Topicals | 55-65% retail margin | $8-18/unit wholesale (as of 2025) | Highest retail margin category but slowest velocity. Medical positioning justifies price. Topicals have strong repeat-purchase behavior for pain management | Stable margins due to lower competitive pressure |

All margin figures as of 2025. Margins vary significantly by state and market maturity. Mature markets (CA, CO, OR) trend toward the lower end of ranges; limited-license and emerging markets (IL, NJ, OH, MN) trend toward the higher end.

Margin floor warning: In the most price-compressed markets (parts of CA, CO, OK as of 2025), some dispensaries report sub-40% blended gross margins. At this level, profitability requires either very high volume, extremely lean operations, or vertical integration (growing your own product). A blended gross margin below 45% should trigger a strategic review.

Payment Term Norms (D-21)

Cannabis payment terms are unusual compared to traditional retail because of limited banking access and cash-dominant operations. The industry is moving toward more standard terms as banking access improves, but cash-based relationships remain common (as of 2025).

| Account Stage | Typical Terms | Negotiation Leverage | Notes | |---------------|---------------|---------------------|-------| | New accounts (first 1-3 orders) | COD (cash on delivery) or prepay | Minimal -- vendor is assessing risk | Standard in cannabis. Do not expect net terms on first order. Some vendors accept ACH or wire for first orders. | | Established accounts (3-6 months) | Net 15-30 | Growing -- purchase history demonstrates reliability | Net 15 is more common than Net 30. Track record of on-time payment is your best negotiating tool. | | High-volume accounts (6+ months, consistent volume) | Net 30, occasionally Net 45 | Significant -- you are a reliable revenue channel | Net 45 is rare but available for top accounts with minimum monthly orders ($10K+). Some MSOs negotiate Net 60. | | Strategic partners | Net 30-45 + promotional allowances | Maximum -- vendor sees you as a marketing channel | Includes co-op marketing funds, demo day support, preferential allocation on limited releases. |

Cannabis-specific payment dynamics:

Cash handling: Many cannabis transactions still involve cash. Vendors who accept ACH or wire transfers are preferred for operational simplicity and safety. Cash pickups require security protocols.
Vendor credits: Industry norm for damaged, expired, or recalled product. Most reputable vendors offer credit for product that fails lab testing post-delivery or arrives damaged. Get credit terms in writing before the first order.
Consignment: Rare but growing practice where vendors place product in-store and get paid after it sells. Benefits for new brands trying to get shelf space. Risk: consignment product may be deprioritized by budtenders.
Volume breaks: Most vendors offer tiered pricing at specific volume thresholds (e.g., 5% discount at 50 units, 10% at 100 units). Always ask -- the first quoted price is rarely the best available price.

Co-Marketing Expectations (D-21)

Vendor marketing support is an increasingly important component of the dispensary-vendor relationship. In mature markets, co-marketing can represent 3-5% of gross vendor revenue (as of 2025).

Pop-up / Demo Days:

Vendor provides brand representative(s) to work in-store for 4-8 hours
Vendor typically provides product samples for staff education (not customer giveaways -- that violates regulations in most states)
Vendor may contribute $100-500 toward in-store signage or promotional materials
Dispensary provides floor space, customer access, and POS integration
Frequency: top vendors do 1-2 pop-ups per month per store; mid-tier vendors 1 per quarter
Expectation: pop-up days should drive 20-40% sales lift for the featured brand on event day (as of 2025)

Menu Placement and Shelf Space:

Emerging practice, especially for vape brands and edible companies
Formal "slotting fees" are rare in cannabis (as of 2025) but brand-funded promotional pricing (vendor-subsidized discounts) effectively serves the same function
Priority shelf placement (eye-level, near register) is a negotiation point for high-volume vendors
Digital menu featuring (top of menu, highlighted sections) increasingly negotiated

Social Media and Content:

Co-branded social media posts (dispensary features vendor product; vendor tags dispensary location)
Vendor-provided product photography for dispensary menus and websites
Joint content creation (strain reviews, extraction process features, brand story videos)
Expectation: vendors with marketing budgets should provide high-quality product images and descriptions at minimum. Any vendor that cannot provide basic marketing assets is underinvesting in retail success.

In-Store Education:

Vendor-funded budtender education sessions (product knowledge, strain details, talking points)
Best practice: quarterly education sessions for each top-5 vendor
Some vendors offer incentive programs for budtender recommendations (SPIFs) -- check local regulations before participating, as some states restrict or prohibit this practice

State-Specific Retail Strategy Notes (D-05)

State-level retail strategy varies based on market maturity, competitive intensity, regulatory environment, and consumer demographics. The notes below are organized by market maturity tier. For full legal status, licensing details, and compliance requirements, see legality.md.

Tier 1: Mature Markets

These markets have 5+ years of legal recreational sales, established competitive dynamics, and well-understood consumer behavior. Retail strategy here is about differentiation in a crowded field.

California

The largest US cannabis market by revenue (~$5B annual legal sales as of 2025) and the most competitive. Open licensing in many jurisdictions has created oversaturation in the LA basin, SF Bay Area, and Sacramento. Price compression is severe -- ounces of outdoor flower available for $60-80 retail in some areas. Vapes overtook flower as the #1 revenue category in late 2025, reflecting California consumers' shift toward convenience. The illicit market remains a significant competitor, with estimates of 60-75% of cannabis consumed in CA still purchased through unlicensed channels (as of 2025).

Retail strategy implications: Value positioning dominates by volume, but premium and lifestyle stores survive in affluent neighborhoods and tourist corridors. Delivery is a major channel (licensed delivery can operate statewide regardless of local bans). Cannabis beverages are a growing category with high margin. Social consumption lounges are emerging in select cities. State excise tax burden (~30% effective rate) compresses margins for all positioning types. Vertical integration or exclusive vendor relationships are near-mandatory for sustained profitability.

Colorado

The first state to launch recreational sales (January 2014) and one of the most mature markets. Price compression has been dramatic -- average flower prices dropped 50%+ from 2020 to 2025. Denver metro is oversaturated; mountain towns and tourist corridors (Aspen, Vail, Boulder, Telluride) sustain premium pricing. Colorado's regulatory environment is relatively stable and business-friendly compared to other states.

Retail strategy implications: Differentiation is critical in Denver. Tourist-focused stores near hotels and entertainment districts sustain premium and lifestyle positioning. Local-serving suburban stores compete on price and convenience. Edibles and concentrates are growing share relative to flower. Colorado consumers are knowledgeable -- premium claims must be backed by genuine quality. The legacy of being "first" gives Colorado a cannabis tourism draw that sustains destination stores.

Washington

Established recreational market since 2014 with heavy price compression. Washington's unique regulatory structure (no vertical integration allowed) creates a clear wholesale-retail separation. I-502 licensing is competitive. Cannabis prices among the lowest in the US (as of 2025).

Retail strategy implications: Margin pressure is severe. Value positioning dominates. Premium positioning viable only in Seattle metro, Bellevue, and tourist-adjacent locations. The lack of vertical integration means all retailers rely on wholesale -- vendor relationships and purchasing efficiency are the primary competitive levers. Pre-roll category disproportionately strong in WA market.

Oregon

Highly oversaturated with the most licenses per capita of any US state. Dramatic price compression -- Oregon wholesale flower prices are among the lowest in the US. The state considered exporting cannabis to other legal states as a surplus solution (as of 2025).

Retail strategy implications: Extreme price competition makes pure value positioning a race to the bottom. Premium positioning viable in Portland and Bend with craft/local branding. Oregon consumers value local, craft, and sustainable -- "farm to table" cannabis resonates here. Outdoor/sun-grown flower has more positive perception in OR than most states. Dispensary consolidation is ongoing as marginal operators exit.

Nevada

Tourism-driven market centered on Las Vegas, with significant local consumer base in Reno and other communities. Higher average prices than CA/CO due to limited licensing and tourist willingness to pay premium. The Las Vegas Strip and downtown corridor support some of the highest per-location revenues in the US.

Retail strategy implications: Tourism positioning is the dominant play on the Strip and in downtown. Planet 13's mega-dispensary model demonstrates the ceiling for experiential retail. Away from the Strip, local-serving dispensaries compete on price and convenience. Nevada consumers (locals) are increasingly price-sensitive as the market matures. Edibles and pre-rolls perform well with tourists (easy, shareable, disposable). Delivery growing but less established than CA.

Michigan

One of the fastest-growing cannabis markets in the US, transitioning from emerging to mature. Open licensing led to rapid dispensary proliferation, especially in metro Detroit and Ann Arbor. Prices falling as supply ramps. Medical program remains significant (as of 2025).

Retail strategy implications: Market is in the "land grab" phase -- location selection and brand building now will pay dividends as the market matures. Value positioning dominates in Detroit metro. Premium viable in Ann Arbor, Grand Rapids, and affluent suburbs. Medical-focused positioning retains value because MI medical cardholders save on taxes. Vape and edible categories growing faster than flower. The caregiver market (home-growing medical patients who can also supply patients) is a unique competitive dynamic in MI.

Illinois

Limited-license market with high barriers to entry. Social equity licensing has expanded access but execution has been slow. Prices remain among the highest in the US due to supply constraints and high tax burden (up to 41.25% effective tax rate on high-potency products). Chicago metro dominates the market.

Retail strategy implications: Limited licensing means less price competition -- premium and medical positioning are viable across most locations. The high tax rate drives consumers to seek value, creating tension between market structure (limited competition favors premium) and consumer behavior (high prices drive deal-seeking). Cross-border competition from Michigan (lower prices) affects southern WI and northern IL locations. Medical cardholders save significantly on taxes, keeping the medical program relevant. Social equity operators entering the market may shift competitive dynamics as new licenses activate.

Massachusetts

Established recreational market (since 2018) with significant regulatory compliance costs. Limited licensing, especially in desirable municipalities. High average prices and margins compared to western markets. Boston metro, Cape Cod, and western MA each have distinct market characteristics.

Retail strategy implications: Limited licensing and high compliance costs create barriers that protect margins for existing operators. Premium positioning viable in Boston, Cambridge, and Cape Cod tourist areas. Value positioning challenging due to high operating costs. Delivery is legal and growing. Cannabis cafe concept emerging in select locations. Competition from Maine (lower prices, no purchase limits for residents) draws customers near the border.

Arizona

Fast-growing market since recreational launch in 2021. Desert markets (Phoenix, Scottsdale, Tucson) and tourist corridor (Sedona, Flagstaff) have distinct dynamics. Medical program established since 2012 provides a foundation of experienced consumers.

Retail strategy implications: Market maturity varies by location -- Phoenix is competitive, smaller cities less so. Premium positioning works in Scottsdale and Sedona. Value positioning growing in Phoenix suburbs. Medical program retains value (tax savings, higher limits). Cannabis tourism emerging as a secondary draw alongside existing AZ tourism. Edibles perform well in the hot climate (outdoor smoking less appealing in summer). Vertical integration common among larger operators.

Tier 2: Growing Markets

These markets have 0-4 years of legal recreational sales or recently launched programs. Retail strategy is about establishing positioning before the market matures.

New York

Recreational sales launched in late 2022 with a troubled rollout. Social equity licensing was prioritized but execution delays left the market undersupplied. Illegal dispensaries (estimated 2,000+ in NYC alone as of 2024) created intense unlicensed competition. Licensed dispensary count remains low relative to population. Prices are moderate because licensed stores must compete with the illicit market on price while bearing compliance costs.

Retail strategy implications: Location selection is paramount -- licensed stores near tourist areas and entertainment districts have the best economics. Competing with the illicit market requires competitive pricing and a clearly superior product/experience. Medical positioning retains value due to established patient base. Market expected to mature significantly 2025-2027 as more licenses activate.

New Jersey

Recreational sales launched April 2022. Limited licensing with high barriers. Proximity to NYC creates a significant cross-border consumer base. Prices among the highest in the US (as of 2025). MSO-dominated early market.

Retail strategy implications: Premium positioning viable given limited competition and high prices. Cross-border traffic from NY and PA creates a tourist-like dynamic. Medical program significant (tax savings, higher limits). As NY market matures and more NJ licenses activate, expect margin compression. Delivery legal and growing.

Connecticut

Recreational sales launched January 2023. Limited licensing with equity provisions. Small state with proximity to NY and MA markets. Early-stage market dynamics.

Retail strategy implications: First-mover advantage is significant in a small, limited-license state. Premium and medical positioning dominate early. Cross-border competition from MA is moderate. Market is too early for value positioning -- supply constraints keep prices high.

Maryland

Recreational sales launched July 2023. Converted from a well-established medical market. Baltimore metro and DC suburbs are primary markets. Tax structure is moderate compared to IL and CA.

Retail strategy implications: The established medical patient base provides a foundation. Premium positioning viable in DC suburbs and affluent Baltimore neighborhoods. Medical-focused positioning retains value because of the established patient community. Market growing quickly with moderate competition.

Missouri

Recreational sales launched February 2023. Rapid growth from established medical program. Limited-license structure with social equity provisions. Kansas City and St. Louis are primary markets.

Retail strategy implications: Fast-growing market with established operators from the medical era. Premium and value positioning both viable depending on location. Cross-border traffic from Kansas (illegal) and Illinois (high taxes) creates additional demand. Medical program remains relevant.

Minnesota

Recreational sales began in 2025. Emerging market with limited supply and high early prices. Twin Cities metro is the primary market.

Retail strategy implications: Very early market -- positioning choices made now will define the competitive landscape. Premium positioning has first-mover advantage. Medical program provides a consumer base to build from. Watch for supply-demand dynamics as more cultivators come online.

Ohio

Recreational sales launched August 2024, converting from medical program. Significant market size (11.7M population). Limited licensing.

Retail strategy implications: Large population creates substantial market opportunity. Medical operators who converted to dual-license have first-mover advantage. Premium and medical positioning strongest early. Value positioning will emerge as supply increases. Cross-border traffic from WV, PA, KY adds demand.

Virginia

Medical sales active; recreational framework still developing (as of 2025). DC proximity creates unique market dynamics.

Retail strategy implications: Medical-focused is currently the only legal positioning. Watch for recreational launch timeline. DC proximity means VA consumers already have access to cannabis through DC's unique gifting market.

Montana

Recreational sales since January 2022. Small population but tourism (Glacier, Yellowstone) creates seasonal demand.

Retail strategy implications: Tourism-driven strategy near national parks. Local-serving stores in Billings, Missoula, Great Falls compete on convenience. Small market supports limited dispensary count.

Vermont

Recreational sales since October 2022. Small market, strong craft culture.

Retail strategy implications: Vermont's brand is craft, local, and artisanal. Premium/boutique positioning aligns with state identity. Market too small for aggressive value competition. Tourism (ski season, fall foliage) creates seasonal demand.

Maine

Recreational sales since October 2020. Growing market with tourism component. No purchase limits for residents.

Retail strategy implications: Tourism-driven in Portland, Bar Harbor, and coastal areas. No purchase limits enables bulk purchasing, supporting value positioning. Cross-border traffic from NH and MA. Craft/artisanal positioning resonates with Maine's culture.

Rhode Island

Recreational sales since December 2022. Smallest state, limited market.

Retail strategy implications: Very small market limits positioning options. Proximity to MA and CT creates cross-border dynamics. Premium positioning viable in Providence and Newport tourist areas.

Delaware

Recreational legalized but sales not yet launched as of 2025. Medical program active.

Retail strategy implications: Watch for recreational launch. Proximity to NJ and PA creates cross-border opportunity. Very small state -- limited dispensary count expected.

Tier 3: Emerging / Medical-Only Markets

These markets are medical-only, recently launched, or have very limited programs. Retail strategy focuses on the medical consumer and regulatory compliance.

Florida -- Largest medical-only market in the US. Vertically integrated operators only (must grow, process, and sell). Trulieve dominant. 2024 recreational ballot measure failed (Amendment 3 got 57% but needed 60%). Medical-focused positioning is the only option. MSO dominance limits independent entry. Over 800K active patients (as of 2025).

Pennsylvania -- Large medical market. Limited licensing. Significant patient base. Recreational legalization efforts ongoing. Premium and medical positioning dominate. Cross-border traffic from NJ.

Oklahoma -- The most open licensing in the US (5,000+ licensed dispensaries for 4M population as of 2024). Extreme oversaturation and price collapse. Medical-only but effectively functions like recreational due to easy card access. Value positioning dominates out of necessity. Many operators unprofitable.

New Mexico -- Recreational since April 2022. Small market. Tourism in Santa Fe and Albuquerque drives premium positioning. Price competition growing as supply ramps.

Alaska -- Recreational since 2016. Small, isolated market. Tourism in Anchorage, Juneau, and Fairbanks supports premium. Limited competition due to geography and population. High operating costs (shipping, energy).

Hawaii -- Medical only. Tourism potential is enormous but regulatory framework limits retail format. Small program with limited dispensaries. Watch for recreational legalization movement.

Louisiana -- Medical only, limited program. Recent expansion to flower products (previously limited to non-smokable forms). Small market, restrictive regulations.

Arkansas -- Medical only. Limited licensing. Small but growing patient base. Cross-border traffic from Texas and surrounding illegal states.

Mississippi -- Medical program launched February 2023. Very early market. Conservative regulatory environment.

North Dakota -- Medical only. Very small market (under 10 dispensaries statewide as of 2025). Limited positioning options.

South Dakota -- Medical only. Small market. Limited program.

Utah -- Medical only. Very restrictive program (14 licensed pharmacies as of 2025). Product format restrictions (no smokable flower). Medical-focused is the only viable positioning.

New Hampshire -- Medical only (Alternative Treatment Centers). Small program. Cross-border traffic from MA and ME for recreational access.

West Virginia -- Medical sales launched January 2024. Very early market. Limited licensing.

Alabama -- Medical program authorized but sales not yet launched as of 2025. Very restrictive framework.

Kentucky -- Medical program authorized, sales expected to begin in 2025. Watch for launch timeline and regulatory framework.

Phase 9 | RETAIL-01, RETAIL-02 | As of 2025